AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 14
- Registration Number
- NCT06514157
- Locations
- 🇨🇳
Research Site, Shanghai, China
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 14
- Registration Number
- NCT06512883
- Locations
- 🇹🇷
Research Site, Altındağ, Turkey
Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 200
- Registration Number
- NCT06511193
- Locations
- 🇨🇦
Research Site, Windsor, Ontario, Canada
A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 398
- Registration Number
- NCT06502366
- Locations
- 🇻🇳
Research Site, Ho Chi Minh, Vietnam
A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 135
- Registration Number
- NCT06502379
- Locations
- 🇺🇸
Research Site, Glendale, California, United States
A Study to Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole in Healthy Participants.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 17
- Registration Number
- NCT06494644
- Locations
- 🇩🇪
Research Site, Berlin, Germany
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1000
- Registration Number
- NCT06494241
- Locations
- 🇨🇳
Research Site, Zhuji, China
NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations
Recruiting
- Conditions
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 600
- Registration Number
- NCT06494540
- Locations
- 🇩🇪
Research Site, Wiesbaden, Germany
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin in Healthy Participants
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 92
- Registration Number
- NCT06491550
- Locations
- 🇺🇸
Research Site, Brooklyn, Maryland, United States
RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
Recruiting
- Conditions
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 250
- Registration Number
- NCT06491862
- Locations
- 🇧🇷
Research Site, Sao Paulo, Brazil
© Copyright 2024. All Rights Reserved by MedPath